All of us produce a growth factor – called IL-15 – which effectively protects us from cancers. It's role is to boost the production of immune cells ...

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 70+ ...

All of us produce a growth factor—called IL-15—which effectively protects us from cancers. Its role is to boost the ...

All of us produce a growth factor – called IL-15 – which effectively protects us from cancers. It's role is to boost the ...

A breakdown of how memory B, T, and innate cells remember past infections and how this insight powers vaccines and immunotherapies.

Novel combination of acimtamig and an allogenic natural killer cell product shows safety and promising objective response ...

We recently published a list of 15 Stocks That Stole The Show Last Week. In this article, we are going to take a look at ...

Fifteen companies skyrocketed by double to triple digits last week, buoyed by fresh company-specific developments and a ...

Dr. Rose has dedicated his career to immunology translational medicine and advancing new treatment options for autoimmune patients. In various leadership roles, he has brought forward more than a ...

Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic.

RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that Andres Isaias, its Chief ...